CytoSorbents Corporation (CTSO)

[dr_lowenstein]

I am always curious when the only arguments presented in support of the CTSO device come from the CEO. Ordinarily, one would conclude that the CEO has a vested interest. At any rate, I thought we should look at what medical experts in the field say. For example:"This can be achieved today with a very specific hemoperfusion process utilizing cartridges with immobilized polymixin B in an extracorporeal circuit. This approach seems to provide a significant removal of endotoxin with a significant reduction of its circulating levels. The clinical consequences of this approach can be summarized in a mitigation of the septic cascade in the early phases, with improvement of outcome. Recent clinical results seem to confirm these expectations showing a reduction of mortality in patients with early signs of abdominal sepsis due to recent surgery. This opens a new avenue for intervention in sepsis."

hmmm, that statement is from Dr John Kellum of the University of Pittsburgh. It is really interesting to note that Dr Kellum is the medical advisor to CTSO. I guess he doesn't think as negatively about the Toray device as the CTSO CEO. go figure.